English | Español
Patient Daily | Mar 16, 2026

AbbVie reports early trial results for weight loss drug ABBV-295
Patient Daily | Mar 16, 2026

Hansoh reports positive Phase 3 results for obesity drug olatorepatide in China
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech
Patient Daily | Mar 16, 2026

Roche reports breast cancer drug giredestrant fails key Phase 3 trial
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape
Patient Daily | Mar 16, 2026

Novo Nordisk to sell GLP-1 drugs through Hims & Hers after ending legal dispute
Patient Daily | Mar 16, 2026

FDA advisory committee to review two AstraZeneca cancer drugs in April meeting
Patient Daily | Mar 16, 2026

Xenon to seek approval of first-in-class epilepsy drug after exceeding Phase 3 expectations

Trending
+ Pharmaceuticals
Patient Daily | May 31, 2026

Roswell Park scientists to present five cancer studies at ASCO annual meeting
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

Immuneering’s pancreatic cancer drug shows extended survival in Phase 2a trial